Any of these alterations to TGFβ1 signaling pathway components can shield tumor cells from the growth inhibitory effects of TGFβ1 while still allowing the tumor-promoting activities of this cytokine to be triggered in other cells within the milieu of the tumor microenvironment. Here, TGFB1 is linked to neoplasm.